LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 19.69 | 84.90 | 55 | 1239 | 0.0444 | -0.1062 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 19.69 | 84.90 | 1117 | 1239 | 0.9012 | 0.9469 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 19.69 | 84.90 | 649 | 1239 | 0.5236 | 0.6919 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 19.69 | 84.90 | 1122 | 1239 | 0.9053 | 0.9492 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 21.40 | 84.90 | 71 | 1454 | 0.0488 | -0.0427 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 21.40 | 84.90 | 1147 | 1454 | 0.7885 | 0.8874 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 21.40 | 84.90 | 960 | 1454 | 0.6600 | 0.8072 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 21.40 | 84.90 | 1157 | 1454 | 0.7954 | 0.8914 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 23.10 | 84.90 | 77 | 1616 | 0.0476 | -0.0227 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 23.10 | 84.90 | 1189 | 1616 | 0.7357 | 0.8607 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 23.10 | 84.90 | 1069 | 1616 | 0.6614 | 0.8147 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 23.10 | 84.90 | 1191 | 1616 | 0.7369 | 0.8614 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 24.81 | 84.90 | 78 | 1769 | 0.0441 | -0.0192 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 24.81 | 84.90 | 1234 | 1769 | 0.6974 | 0.8421 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 24.81 | 84.90 | 1143 | 1769 | 0.6460 | 0.8101 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 24.81 | 84.90 | 1231 | 1769 | 0.6957 | 0.8410 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 26.51 | 84.90 | 74 | 1923 | 0.0385 | -0.0301 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 26.51 | 84.90 | 1279 | 1923 | 0.6651 | 0.8268 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 26.51 | 84.90 | 1195 | 1923 | 0.6214 | 0.7994 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 26.51 | 84.90 | 1289 | 1923 | 0.6703 | 0.8299 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 28.21 | 84.90 | 84 | 2091 | 0.0402 | -0.0023 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 28.21 | 84.90 | 1351 | 2091 | 0.6459 | 0.8196 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 28.21 | 84.90 | 1273 | 2091 | 0.6087 | 0.7963 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 28.21 | 84.90 | 1337 | 2091 | 0.6393 | 0.8155 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 29.92 | 84.90 | 95 | 2237 | 0.0425 | 0.0241 | MN20160318_Q02 | C22 |